Association of ANRIL Gene Polymorphisms with Gastric Cancer Risk: A Case–Control Study
Genetic Testing and Molecular Biomarkers · 2024
DOI: 10.1089/gtmb.2024.0302 ↗Kurz gefasst
Fachartikel in der Zeitschrift Genetic Testing and Molecular Biomarkers, 2024. Verfasst von Samaneh Hasani und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Biochemistry, School of Medicine, Ardabil University of Medical Sciences, Ardabil, Iran. Hauptthemen laut MEDLINE: Stomach Neoplasms, RNA, Long Noncoding, Polymorphism, Single Nucleotide, Genetic Predisposition to Disease. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 48 Literaturangaben.
Abstract (Originalsprache)
Background
Gastric cancer's (GC) cause is unknown, but its complexity indicates that, in addition to environmental factors, it may have genetic origins. Scientists are studying single-nucleotide polymorphisms (SNPs) in the antisense noncoding RNA in the INK4 locus (ANRIL) gene, which encodes a long noncoding RNA molecule. They found a link between the ANRIL gene product and some polymorphisms and GC, suggesting genetic changes may lead to precancerous conditions.
Methods
In a case-control research that included 250 patients with GC and 210 controls who were age- and gender-matched, four SNPs within the ANRIL gene were genotyped. These SNPs were rs1333049, rs496892, rs2383207, and rs2151280. Tetra-primer amplification refractory mutation system-PCR was utilized to carry out the process of genotyping.
Results
It was found that the chance of developing GC was connected with three SNPs rs2151280, rs1333049, and rs496892. Nevertheless, rs2383207 did not demonstrate any meaningful connection. In addition, whereas CCTC and TTCC haplotypes were shown to be less common, certain haplotypes that contained these SNPs (TTCG, TCTC, and TTTC) displayed a considerably higher prevalence in the cancer group in comparison to the control group.
Conclusion
This study showed novel associations between specific ANRIL gene polymorphisms (SNPs) and the risk of GC. These findings shed light on the potential role of ANRIL SNPs in GC risk and highlight the need for additional research to clarify the underlying functional processes. Understanding these functional processes might lead to developing novel diagnostic or treatment approaches for this cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Biochemistry, School of Medicine, Ardabil University of Medical Sciences, Ardabil, Iran.
- Digestive Disease Research Center, Ardabil University of Medical Sciences, Ardabil, Iran.
ORCID-Profile: Aliakbar Fazaeli
Zitieren
APA
Hasani, S., Pourfarzi, F., Mazani, M., Yazdanbod, A., & Fazaeli, A. (2024). Association of ANRIL Gene Polymorphisms with Gastric Cancer Risk: A Case–Control Study. Genetic Testing and Molecular Biomarkers. https://doi.org/10.1089/gtmb.2024.0302
Vancouver
Hasani S, Pourfarzi F, Mazani M, Yazdanbod A, Fazaeli A. Association of ANRIL Gene Polymorphisms with Gastric Cancer Risk: A Case–Control Study. Genetic Testing and Molecular Biomarkers. 2024. doi:10.1089/gtmb.2024.0302
BibTeX
@article{Hasani2024,
author = {Hasani, Samaneh and Pourfarzi, Farhad and Mazani, Mohammad and Yazdanbod, Abbas and Fazaeli, Aliakbar},
title = {Association of ANRIL Gene Polymorphisms with Gastric Cancer Risk: A Case–Control Study},
journal = {Genetic Testing and Molecular Biomarkers},
year = {2024},
doi = {10.1089/gtmb.2024.0302}
}
EUVIMED